1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
685F1A4322D34DA9885258044005F5F04
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/85F1A4322D34DA9885258044005F5F04!OpenDocument
18
19OpenDocument
203.233.219.103
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » New Product Development » New Product Planning

Document Excerpt: Pharmaceutical New Product Planning Excellence: Resources and Showing Value

DB Image

ID: MD-536


Features:

18 Info Graphics

17 Data Graphics

125 Metrics

7 Narratives


Pages/Slides: 4


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".


To return to the study abstract to purchase the full study - click here.

This excerpt includes research findings and metrics from document #5435 "Pharmaceutical New Product Planning Excellence: Resources and Showing Value"


Industries Profiled:
Biopharmaceutical; Pharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic


Companies Profiled:
Alkermes; Zydus Cadila; GlaxoSmithKline ; Astellas; Roche; Novartis; Sanofi; Pfizer; Takeda Pharmaceuticals; Cytokinetics; Allergan; Medicago; Bayer; Galderma; Wockhardt

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.